PainWeek Booth Presentation: Managing Costs Associated with Chronic Pain by Early Detection of Nonadherence & Cost-conscious Urine Drug Monitoring
The requirements for urine drug testing in chronic pain management patients are different from that for traditional drugs of abuse testing. This presentation will discuss cost saving strategies for monitoring pain management patient adherence and propose clinical laboratory testing models.
Originally presented on September 06, 2012 in Las Vegas, Nevada.
Gordon Nelson, C(ASCP), NRCC-TC
Vice President Chemistry Division, ARUP Laboratories
Mr. Nelson is a technical vice president and division manager of the Chemistry Division at ARUP. The Chemistry Division includes Analytic Biochemistry, Clinical Drug Abuse Testing, Mass Spectrometry 1, Mass Spectrometry 2, Toxicology, Trace Elements and Calculi, Automated Core, Automated Endocrinology, Electrophoresis Manual Endocrinology, Manual Endocrinology, and Special Chemistry laboratories. Mr. Nelson has more than 20 years of laboratory experience. He is certified in chemistry by the American Society for Clinical Pathology (ASCP) and as a toxicological chemist by the National Registry of Certified Chemists. He is an inspector for the National Laboratory Certification Program conducted by the Division of Health and Human Services. Mr. Nelson received his BS degree from the University of Utah.